Ondansetron has similar clinical efficacy against both nausea and vomiting

Anaesthesia

Volumn 64, Issue 2, 2009, Pages 147-151

  Jokela, R M ^a   Cakmakkaya, O S ^b   Danzeisen, O ^d   Korttila, K T ^e   Kranke, P ^f   Malhotra, A ^c   Paura, A ^g   Radke, O C ^c   Sessler, D I ^h   Soikkeli, A ^a   Roewer, N ^f   Apfel, C C ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g Hospital Lüneburg   (Germany)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PLACEBO; ANTIEMETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; ANESTHESIA, GENERAL; ANTIEMETICS; FEMALE; HUMANS; MALE; MIDDLE AGED; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; RISK FACTORS;

EID: 59449100563     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05732.x     Document Type: Article

References (14)

1. Koivuranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52: 443-9.
2. Eberhart LHJ, Hogel J, Seeling W, Staack AM, Geldner G, Georgieff M. Evaluation of three risk scores to predict postoperative nausea and vomiting. Acta Anaesthesiologica Scandinavica 2000; 44: 480-8.
3. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59: 213-43.
4. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesthesia & Analgesia 2003; 97: 62-71, table of contents.
5. Tramer MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part II. Recommendations for prevention and treatment, and research agenda. Acta Anaesthesiologica Scandinavica 2001; 45: 14-9.
6. Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiologica Scandinavica 2002; 46: 921-8.
7. Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003; 98: 46-52.
8. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997; 87: 1277-89.
9. Apfel CC, Korttila K, Abdalla M, et al. An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2 × 2 × 2 × 2 × 2 × 2 factorial design (IMPACT). Controlled Clinical Trials 2003; 24: 736-51.
10. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. New England Journal of Medicine 2004; 350: 2441-51.
11. Make B. How can we assess outcomes of clinical trials: the MCID approach. Copd 2007; 4: 191-4.
12. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
13. Sun R, Klein KW, White PF. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery. Anesthesia & Analgesia 1997; 84: 331-6.
14. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesthesia & Analgesia 1998; 86: 274-82.